Hepatitis B Virus Treatment: Which Patients Require Immediate Treatment

Overview

Journal Clin Liver Dis (Hoboken)

Specialty Gastroenterology

Date 2019 Apr 18

PMID 30992812

Citations 1

Authors

Robert P Perrillo

Affiliations

Soon will be listed here.

Citing Articles

Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure.

Manik A, Malakar D, Noor-E-Alam S, Mahtab M, Das D, Mamun A J Family Med Prim Care. 2021; 10(6):2376-2380.

PMID: 34322441 PMC: 8284233. DOI: 10.4103/jfmpc.jfmpc_2300_20.

References

Lok A, McMahon B . Chronic hepatitis B: update 2009. Hepatology. 2009; 50(3):661-2. DOI: 10.1002/hep.23190. View

Huang K, Hu J, Wang H, He W, Chen J, Duan X . Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol. 2011; 17(29):3448-52. PMC: 3160571. DOI: 10.3748/wjg.v17.i29.3448. View

Liaw Y, Sheen I, Lee C, Salih Akarca U, Papatheodoridis G, Wong F . Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease. Hepatology. 2011; 53(1):62-72. DOI: 10.1002/hep.23952. View

Perrillo R, Wright T, Rakela J, Levy G, Schiff E, Gish R . A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology. 2001; 33(2):424-32. DOI: 10.1053/jhep.2001.21554. View

Liaw Y, Sung J, Chow W, Farrell G, Lee C, Yuen H . Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004; 351(15):1521-31. DOI: 10.1056/NEJMoa033364. View

Chang T, Liaw Y, Wu S, Schiff E, Han K, Lai C . Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010; 52(3):886-93. DOI: 10.1002/hep.23785. View

Dao D, Seremba E, Ajmera V, Sanders C, Hynan L, Lee W . Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure. Dig Dis Sci. 2011; 57(5):1349-57. PMC: 3565239. DOI: 10.1007/s10620-011-2013-3. View

Kumar M, Satapathy S, Monga R, Das K, Hissar S, Pande C . A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology. 2006; 45(1):97-101. DOI: 10.1002/hep.21486. View

Dao D, Hynan L, Yuan H, Sanders C, Balko J, Attar N . Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels. Hepatology. 2011; 55(3):676-84. PMC: 3272543. DOI: 10.1002/hep.24732. View

10.

Schiff E, Lai C, Hadziyannis S, Neuhaus P, Terrault N, Colombo M . Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transpl. 2007; 13(3):349-60. DOI: 10.1002/lt.20981. View

11.

Garg H, Sarin S, Kumar M, Garg V, Sharma B, Kumar A . Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011; 53(3):774-80. DOI: 10.1002/hep.24109. View

12.

Tillmann H, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C . Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat. 2006; 13(4):256-63. DOI: 10.1111/j.1365-2893.2005.00695.x. View

13.

Liaw Y, Raptopoulou-Gigi M, Cheinquer H, Sarin S, Tanwandee T, Leung N . Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study. Hepatology. 2011; 54(1):91-100. DOI: 10.1002/hep.24361. View

14.

Fontana R, Hann H, Perrillo R, Vierling J, Wright T, Rakela J . Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology. 2002; 123(3):719-27. DOI: 10.1053/gast.2002.35352. View